Wells Fargo & Company Biodesix Inc Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Biodesix Inc stock. As of the latest transaction made, Wells Fargo & Company holds 893,203 shares of BDSX stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

893,203

Previous 883,653 1.08%

Holding current value

$1.58 Million

Previous $1.63 Million 21.42%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.35 - $2.12 $12,892 - $20,246	9,550 Added 1.08%	893,203 $1.28 Million
Q4 2023 Feb 09, 2024	BUY	$1.2 - $2.13 $6,603 - $11,721	5,503 Added 0.63%	883,653 $1.63 Million
Q3 2023 Nov 13, 2023	BUY	$1.04 - $1.74 $37,076 - $62,031	35,650 Added 4.23%	878,150 $1.45 Million
Q2 2023 Aug 15, 2023	BUY	$1.12 - $1.88 $45,071 - $75,654	40,242 Added 5.02%	842,500 $1.04 Million
Q1 2023 May 12, 2023	BUY	$1.52 - $2.5 $43,204 - $71,060	28,424 Added 3.67%	802,258 $1.49 Million

Q4 2022 Feb 13, 2023	BUY	$1.01 - $2.3 $5,058 - $11,518	5,008 Added 0.65%	773,834 $1.78 Million
Q3 2022 Nov 14, 2022	BUY	$1.28 - $2.89 $283,377 - $639,814	221,389 Added 40.44%	768,826 $984,000
Q2 2022 Aug 12, 2022	SELL	$1.32 - $2.12 $2,848 - $4,574	-2,158 Reduced 0.39%	547,437 $826,000
Q1 2022 May 16, 2022	BUY	$1.69 - $5.81 $915,900 - $3.15 Million	541,953 Added 7091.77%	549,595 $918,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $8.67 $24,466 - $51,863	5,982 Added 360.36%	7,642 $40,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $12.78 $4,910 - $9,508	744 Added 81.22%	1,660 $14,000
Q2 2021 Aug 16, 2021	SELL	$12.14 - $20.35 $11,193 - $18,762	-922 Reduced 50.16%	916 $12,000
Q1 2021 May 13, 2021	SELL	$16.87 - $31.21 $8,013 - $14,824	-475 Reduced 20.54%	1,838 $37,000
Q4 2020 Feb 09, 2021	BUY	$10.89 - $20.16 $25,188 - $46,630	2,313 New	2,313 $47,000

Others Institutions Holding BDSX

# of Institutions

Shares Held

16.2M

Call Options Held

Put Options Held

View Full List

About BIODESIX INC

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $70.8M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

More about BDSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Biodesix Inc Transaction History